Picard Medical, Inc. PMI
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 41.00% | 80.70% | 12.66% | 8.97% | 1.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 41.00% | 80.70% | 12.66% | 8.97% | 1.52% |
| Cost of Revenue | -6.59% | 17.18% | 14.39% | -8.48% | -0.29% |
| Gross Profit | 214.68% | 133.59% | -82.14% | 64.75% | 7.51% |
| SG&A Expenses | 15.06% | 4.89% | -2.11% | -12.71% | -5.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.92% | 10.39% | 0.56% | -8.96% | -0.63% |
| Operating Income | -5.73% | 3.74% | 3.32% | 13.86% | 1.27% |
| Income Before Tax | -2.45% | -17.88% | -27.99% | -73.15% | -78.62% |
| Income Tax Expenses | -31.25% | -75.00% | 333.33% | 900.00% | 900.00% |
| Earnings from Continuing Operations | -2.43% | -17.82% | -28.25% | -73.26% | -78.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.43% | -17.82% | -28.25% | -73.26% | -78.75% |
| EBIT | -5.73% | 3.74% | 3.32% | 13.86% | 1.27% |
| EBITDA | -5.75% | 4.04% | 2.91% | 13.11% | -0.51% |
| EPS Basic | 88.85% | 65.75% | 37.18% | -14.80% | -64.12% |
| Normalized Basic EPS | 88.63% | 65.58% | 35.87% | -19.68% | -73.17% |
| EPS Diluted | 88.85% | 65.75% | 37.18% | -14.80% | -64.12% |
| Normalized Diluted EPS | 88.63% | 65.58% | 35.87% | -19.68% | -73.17% |
| Average Basic Shares Outstanding | 750.83% | 537.74% | 328.92% | 121.98% | -24.39% |
| Average Diluted Shares Outstanding | 750.83% | 537.74% | 328.92% | 121.98% | -24.39% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |